Digilab BioVisioN GmbH

Digilab BioVisioN is a wholly-owned subsidiary of Digilab, Boston. Digilab BioVisioN collaborates with companies in the pharmaceutical and diagnostics fields, analytical instrument hardware and software, consumables suppliers, academic institutions, and government agencies. Digilab BioVisioN utilizes its internationally patented Peptidomics® technology platform to provide products and services for biomarker research and development. In addition to pre-analytical products and services for specimen generation, peptide enrichment, protein depletion, and MALDI mass spectrometry, Digilab BioVisioN also offers comprehensive biomarker discovery projects to the life sciences industry under its brand DigilabPeptidomics®.